Gail Gauvreau

Professor Gail Gauvreau is a leading academic in the Department of Medicine at McMaster University, specializing in Allergic Asthma, Immunology, and Respiratory Diseases. Her research focuses on allergen-induced immune responses, cytokine signaling, and therapeutic interventions in asthma and atopic conditions.

• Key research areas: Eosinophil biology, IL-33/ST2 axis, TSLP pathway
• Recent work: SARS-CoV-2 receptor expression in asthmatics, anti-alarmin therapies, and inhaled vaccine development
• Major collaborations: Clinical trials with biologics (Benralizumab, Ligelizumab) and inhalation challenge studies

Her 15 most recent publications (2025-2024) emphasize airway inflammation, immune cell regulation, and novel therapeutic approaches, with a focus on real-time clinical models and molecular biomarkers. Notably, her 2025 study on Benralizumab in atopic dermatitis and 2024 work on neuromedin-U in asthma highlight translational impact.